Revenue
$0
Net Income
-$223.1M
▲ 13.8% YoY
EPS
$-2.01
▲ 26.4% YoY
Cash
$77.6M
▼ 52.6% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Militello John See Remarks | Sell | Feb 18, 2026 | 1.2K | $3.34 | $4K | Form 4 ↗ |
Shah Gaurav CEO | Sell | Feb 18, 2026 | 6.0K | $3.34 | $20K | Form 4 ↗ |
Wilson Martin General Counsel | Sell | Feb 18, 2026 | 1.4K | $3.34 | $5K | Form 4 ↗ |
Wilson Martin General Counsel | Sell | Feb 13, 2026 | 12.3K | $3.31 | $41K | Form 4 ↗ |
Militello John See Remarks | Sell | Feb 13, 2026 | 3.7K | $3.31 | $12K | Form 4 ↗ |
Shah Gaurav CEO | Sell | Feb 13, 2026 | 12.3K | $3.31 | $41K | Form 4 ↗ |
Shah Gaurav CEO | Grant | Feb 11, 2026 | 286.0K | $0.00 | $0 | Form 4 ↗ |
Militello John See Remarks | Grant | Feb 11, 2026 | 30.0K | $0.00 | $0 | Form 4 ↗ |
Wilson Martin General Counsel | Grant | Feb 11, 2026 | 311.8K | $0.00 | $0 | Form 4 ↗ |
Rizvi Syed Ali-aamir Chief Medical Officer | Grant | Feb 11, 2026 | 62.0K | $0.00 | $0 | Form 4 ↗ |
Stevens Christopher James Chief Operating Officer | Grant | Feb 11, 2026 | 62.0K | $0.00 | $0 | Form 4 ↗ |
Chaudhuri Sarbani See Remarks | Grant | Feb 11, 2026 | 125.9K | $0.00 | $0 | Form 4 ↗ |